Related Experiment Video

Updated: Dec 30, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.5K

Optimal Patient Selection using Objective Parameters for Impella Left Ventricular Assist Device Therapy

Teruhiko Imamura1, Nikhil Narang2

  • 1Second Department of Medicine, University of Toyama, Toyama, Japan.

Cardiovascular Revascularization Medicine : Including Molecular Interventions
|January 19, 2020
PubMed
Summary

No abstract available in PubMed .

Keywords:
Heart failureHemodynamicsUnloading

More Related Videos

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.2K
Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.9K

Related Experiment Videos

Last Updated: Dec 30, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.5K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.2K
Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.9K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

255
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
255
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

203
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
203

Articles linked to this work by shared authors, journal, and citation graph.

Potential Impact of the OPTN Status Escalation Policy for Adult Heart Transplant Candidates With Durable LVADs.

Circulation. Heart failure·2026

High Rate of Transplantation Before Review of Status Exception Requests Among Adult Heart Transplant Candidates.

Circulation. Heart failure·2026

Artifactual declines in durable LVAD utilization among heart transplant candidates: Selection bias in transplant registries.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Compensating Heart Failure Cardiologists: Is the RVU Model the Right Model?

Circulation. Heart failure·2026

Status Exceptions and Misalignment of Medical Urgency in U.S. Pediatric Heart Transplantation.

Journal of the American College of Cardiology·2026

Variability in Status 1 Exception Practices and Candidate Outcomes After the 2018 US Heart Allocation Changes.

Journal of cardiac failure·2026

One-year clinical outcomes after drug-coated balloon-only angioplasty for de novo lesions in non-small coronary vessels.

Cardiovascular revascularization medicine : including molecular interventions·2026

Expert perspectives on de-escalation of antiplatelet therapy - Beyond the guidelines: Insights from the cardiovascular research technologies 2026 meeting.

Cardiovascular revascularization medicine : including molecular interventions·2026

Association of increased coronary physiology and intracoronary imaging use with downstream healthcare costs.

Cardiovascular revascularization medicine : including molecular interventions·2026

Post-market safety profile of the CardioMEMS HF System: A MAUDE disproportionality and network analysis.

Cardiovascular revascularization medicine : including molecular interventions·2026

Incidence and prognostic value of electrocardiographic changes in patients with myocardial injury after elective PCI.

Cardiovascular revascularization medicine : including molecular interventions·2026

Eyeballing versus comprehensive geriatric frailty assessment and outcomes after transcatheter aortic valve replacement: Insights from a large cohort.

Cardiovascular revascularization medicine : including molecular interventions·2026

Innovative microneedle-integrated hydrogels: a promising strategy for diabetic foot ulcer management.

Frontiers in bioengineering and biotechnology·2026

A Systematic Review of Three-Dimensional Printing in Medical Education: Educational Impact and Methodological Quality.

Journal of medical education and curricular development·2026

Efficacy differences and predictors of personalized mixed acoustic therapy in chronic tinnitus patients with and without hearing loss.

Frontiers in neurology·2026

Immuno-phage synergy driven by fitness costs: turning bacterial phage resistance into therapeutic gain through evolutionary traps.

Frontiers in immunology·2026

Inhibiting the uPAR/FPR1 interactions reduces blood-retinal barrier breakdown and improves retinal function in a rat model of diabetes.

Frontiers in neuroscience·2026

Nanostructured Surface Modifications for Cardiac Implants: From Bench to Bedside.

Current cardiology reviews·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us